Walmart has settled a lawsuit filed by the U.S. Department of Justice in 2020 over claims that its pharmacies filled hundreds of thousands of illegal prescriptions for controlled substances that contributed to the opioid crisis. The Department of Justice and Walmart confirmed the settlement in separate statements, with some reports citing a $50 million payment while others noted the terms were not disclosed. The resolution is described as part of a broader government effort to hold retailers and pharmacists accountable for their roles in the opioid epidemic.
The New York Times frames the settlement briefly as part of a broader government effort to hold retailers and pharmacists accountable for the opioid epidemic, with minimal detail in the sampled excerpt.
CNBC reports the settlement without disclosing terms (noting the DOJ and Walmart statements did not disclose amount), emphasizing case history, the scale of the opioid epidemic (905,000+ deaths since 1999), prior related litigation (Purdue Pharma, Cencora), and Walmart's 2022 $3.1 billion state/local settlement, framing this as one of the most significant DOJ cases against a single company over opioids.
No right-of-center outlet in our set has published this story.